Timolol ophthalmic (Betaliq)

噻吗洛尔 (Betaliq)

Report date: 2024/07/12 16:53:51

Base Information

Drug NameTimolol ophthalmic (Betaliq)
Drug Alias NameBTQ-1902
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBetaliq Inc
China Registration ClassN/A

Develop Information

Active CompaniesBetaliq Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A